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Hematopoietic development and vascular develop-
ment are closely related physiological processes
during vertebrate embryogenesis. Recently, endo-
thelial-to-hematopoietic transition (EHT) was dem-
onstrated to be critical for hematopoietic stem and
progenitor cell induction, but its underlying regula-
tory mechanisms remain poorly understood. Here
we show that thrombin receptor (F2r), a protease-
activated G protein-coupled receptor required for
vascular development, functions as a negative
regulator during hematopoietic development. F2r
is significantly upregulated during hematopoietic
differentiation of mouse embryonic stem cells
(mESCs) and zebrafish hematopoietic development.
Pharmacological or genetic inhibition of F2r
promotes hematopoietic differentiation, whereas
F2r overexpression shows opposite effects. Further
mechanistic studies reveal that F2r-RhoA/ROCK
pathway inhibits EHT in vitro and negatively regu-
lates zebrafish EHT and hematopoietic stem cell
induction in vivo. Taken together, this study demon-
strates a fundamental role of F2r-RhoA/ROCK
pathway in vertebrate hematopoiesis and EHT, as
well as an important molecular mechanism coordi-
nating hematopoietic and vascular development.
INTRODUCTION
There are two consecutive waves of hematopoiesis in verte-
brates, namely primitive hematopoiesis and definitive hemato-
poiesis. Primitive hematopoiesis refers to the production of
primitive erythrocytes during early embryogenesis, whereas
definitive hematopoiesis is characterized by the occurrence1092 Developmental Cell 22, 1092–1100, May 15, 2012 ª2012 Elseviof hematopoietic stem cells (HSCs) and their subsequent differ-
entiation into all lineages of bloods cells (Orkin and Zon, 2008).
Importantly, recent studies showed that the earliest hematopoi-
etic progenitor cells derive from hemogenic endothelial cells
during hematopoietic differentiation of mouse embryonic stem
cells (mESCs), without apparent signs of asymmetric cell division
(Eilken et al., 2009; Lancrin et al., 2009). In vivo time-lapse
imaging studies also demonstrated that HSCs emerge directly
from aortic hemogenic endothelial cells in the zebrafish and
mouse embryos (Bertrand et al., 2010a; Boisset et al., 2010;
Kissa and Herbomel, 2010). This type of cell transition, called
endothelial-to-hematopoietic transition (EHT), plays a funda-
mental role in the generation of hematopoietic stem and pro-
genitor cells, but how it is regulated by the environmental signals
still remains elusive. Interestingly, the process of EHT is reminis-
cent of epithelial to mesenchymal transition (EMT), both of which
are characterized by tight-junction dissolution, loss of cell
polarity, increased cell mobility, and gain of stem cell-like prop-
erties (Thiery et al., 2009). Whether these two types of cell
transition share common regulatory mechanisms also remains
to be determined.
G protein-coupled receptors (GPCRs) belong to the largest
and most versatile cell-surface receptor superfamily. They
receive and transmit a variety of environmental signals into the
cell, and actively participate in the regulation of immune
responses and higher recognitions (Gainetdinov et al., 2004;
Marinissen and Gutkind, 2001). Recently, prostaglandin E2
receptor signaling was shown to regulate HSC homeostasis
through genetically interacting with Wnt pathway (Goessling
et al., 2009; North et al., 2007). Besides, we also identified that
b-arrestin1, an important GPCR signaling molecule, is essential
for zebrafish primitive hematopoiesis, further suggesting that
GPCR signaling plays important roles during vertebrate hemato-
poiesis (Yue et al., 2009). Thrombin receptor (F2r), also called
protease-activated receptor 1 (PAR1), is a prototypical GPCR
activated by thrombin (F2) as well as other proteases. After
cleavage of the extreme N-terminal peptide, the exposed
tethered ligand of F2r activates itself, and participates in sucher Inc.
Figure 1. F2r Is Significantly Upregulated
during Hematopoiesis
(A) Three distinct GPCR expression patterns
during mESC differentiation.
(B) Expression patterns of F2r, Antithrombin,
Cmyb, and Pu.1 in the microarray data.
(C–F) qPCR analyses of F2r and F2 expressions
during mESC hematopoietic differentiation (C and
D) and zebrafish embryogenesis (E and F).
(G) WISH analyses of F2r expression pattern at
different stages of zebrafish embryogenesis.
Arrows indicate ICM region at 22 hpf and AGM
region at 36 hpf.
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F2r Regulates Hematopoiesis and EHTdiverse physiological processes as coagulation, inflammation,
and vascular homeostasis (Leger et al., 2006). Interestingly,
nearly half of the F2r knockout mice died in midgestation due
to impaired vascular development and severe bleeding, whereas
endothelial cell-specific reintroduction of F2r rescued the
phenotype (Griffin et al., 2001). Because vascular development
and hematopoietic development closely associate with each
other, it is highly possible that F2r signaling also regulates
hematopoiesis.
Combining with bioinformatic, pharmacological, and genetic
analyses, we identified F2r signaling as a negative regulator of
vertebrate hematopoiesis both in vitro and in vivo. More impor-Developmental Cell 22, 1092–11tantly, RhoA/ROCK pathway was identi-
fied to function downstream of F2r,
revealing an important regulatory mecha-




To identify potential GPCRs regulating
vertebrate hematopoiesis, we analyzed
two microarray data sets characterizing
the gene expression profiles of mESC
differentiation (Hailesellasse Sene et al.,
2007). Clustering analysis showed that
there are three patterns of differentially
expressed GPCRs (Figure 1A), in which
six receptors were identified as statisti-
cally significant in both J1 and R1
mESCs (data not shown). Gene ontology
(GO) analysis showed that one of
these GPCRs, F2r or PAR1, plays key
roles in circulatory system and func-
tions as a positive regulator of blood
coagulation and vascular development
(GO:0007596). F2r is constitutively up-
regulated and negatively correlated
with hematopoietic transcription factors
cmyb and pu.1 (cmyb: Pearson correla-
tion r = 0.60, p = 0.05; pu.1: Pearson
correlation r = 0.55, p = 0.08). In addi-
tion, the expression pattern of anti-thrombin, an inhibitor of F2 and coagulation (Olds et al., 1994;
Olson and Bjo¨rk, 1994), is positively correlated with that of
cmyb (Pearson correlation r = 0.66, p = 0.03), suggesting the
negative correlation between F2r signaling and hematopoiesis
(Figure 1B).
Next, we set up a mESC hematopoietic differentiation system
(McKinney-Freeman et al., 2008), and confirmed the expression
patternofF2rusing real-timequantitativePCR (qPCR;Figure1C).
Interestingly, prothrombin (F2), the prototypical activating
protease of F2r, is also significantly upregulated during hemato-
poietic differentiation (Figure 1D). To evaluate the physiological
relevanceof F2r signaling in vivo,wedetected the spatiotemporal00, May 15, 2012 ª2012 Elsevier Inc. 1093
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F2r Regulates Hematopoiesis and EHTexpression of F2r and F2 during zebrafish embryogenesis.
Consistent with the mESC hematopoietic differentiation model,
bothF2r andF2were significantly upregulated after 12 hr postfer-
tilization (hpf; Figures 1E and 1F). In addition, whole-mount in situ
hybridization (WISH) analyses revealed that F2r mRNA mainly
localized in the vascular endothelium, and closely associated
with primitive hematopoietic site (intermediate cell mass, ICM)
at 22 hpf and definitive hematopoietic site (aorta-gonad-
mesonephros, AGM) at 36 hpf (Figure 1G). Interestingly, this
expression pattern is nearly identical to that of zebrafish F2 as
previously reported (Day et al., 2004), indicating that F2r signaling
is functionally active during hematopoietic development.
F2r Negatively Regulates mESC Hematopoietic
Differentiation
To elucidate the role of F2r signaling duringmESC hematopoietic
differentiation, we used both pharmacological and genetic
approaches to modulate F2r signal transduction. CD41 is the
earliest cell surface hematopoietic marker and indicates the
efficiency of hematopoietic differentiation. Application of F2r-
specific antagonist SCH79797 significantly increased CD41+
cell percentage (Figures 2A–2C). This effectwas dose dependent
and most striking when SCH79797 was added from embryoid
body (EB) day 2 to day 6 (Figure 2D, and see Figure S1A available
online). Consistently, qPCR analyses revealed that hematopoi-
etic transcription factors gata1, scl, cmyb, and runx1, as well as
b-h1 and b-major hemoglobins, were all upregulated following
SCH79797 treatment (Figure 2E). In contrast, the marker genes
for the three germ layers were not generally affected (Li et al.,
2010) (Figure S1B). We also performed methylcellulose-based
colony-forming cell assay (M3434), a functional assay that
measures both hematopoietic progenitor types and numbers.
F2r antagonism significantly increased primitive erythroid (Ery-
P) numbers (Figure 2F), as well as definitive erythroid (cfu-E)
and granulocyte/monocyte (cfu-G/M/GM) numbers (Figure 2G).
To rule out the nonspecific effects of SCH79797 (Di Serio et al.,
2007), we knocked down F2r with two independent siRNAs (Fig-
ure S1C). Consistent with the F2r antagonism results, genetic
inhibition of F2r significantly increased CD41+ cell percentage
and the expression of hematopoietic markers (Figures 2H and
2I), without affecting the formation of three germ layers (Fig-
ure S1D). In addition, the Ery-P numbers (Figures 2J and S1E),
as well as cfu-E and cfu-G/M/GM numbers, were all increased
after F2r knockdown (Figures 2K and S1F), indicating that F2r
inhibition promotes mESC hematopoietic differentiation.
On the other hand, application of F2r agonist peptide TFLLR-
NH2 did not inhibit hematopoietic differentiation (data not
shown), possibly due to the fact that endogenous F2 is dramat-
ically increased during differentiation (Figure 1D), which acti-
vates F2r at even subnanomolar range (Leger et al., 2006).
However, we did find that overexpressing F2r inhibited CD41+
cell percentage and the expression of hematopoietic marker
genes (Figures S1G–S1I). Taken together, these results demon-
strated that F2r signaling negatively regulates mESC hematopoi-
etic differentiation.
F2r-RhoA/ROCK Pathway Regulates EHT In Vitro
Next, we tried to explore the downstream mechanisms of F2r
signaling during hematopoietic differentiation. We first hypothe-1094 Developmental Cell 22, 1092–1100, May 15, 2012 ª2012 Elsevisized that F2r signaling may crosstalk with known hematopoietic
pathways. To test this hypothesis, we applied SCH79797
together with the inhibitors of BMP pathway, FGF pathway,
Hedgehog pathway, Notch pathway, or NO pathway, and
analyzed their corresponding effects on mESC hematopoietic
differentiation (Zon, 2008). Consistent with the fact that BMP
pathway is a crucial initiator of mesoderm and hematopoiesis
(So¨derberg et al., 2009), inhibition of BMP pathway completely
blocked hematopoietic differentiation. In contrast, inhibition of
other pathways did not significantly abolish the effects of
SCH79797, suggesting that pathway crosstalk may not be the
main mechanism, and that F2r may directly regulate hematopoi-
etic differentiation through its downstream signaling events
(Figure S2A).
F2r couples to G12/13, Gq, and Gi, and transmits extracellular
signals by activating RhoA/ROCK and PKC, or by inhibiting
cAMP production (Hung et al., 1992; Lidington et al., 2000;
Vouret-Craviari et al., 2002). To substantiate which pathway
mediates F2r signaling, we applied inhibitors of ROCK, Rac1,
Gi, or PKC during mESC hematopoietic differentiation, and
compared their effects with that of SCH79797. Interestingly,
ROCK inhibitors Y-27632 and H1152 significantly increased
CD41+ cell percentage, whereas Rac1, Gi, and PKC inhibitors
had no such effects (Figure S2B). GTPase pull-down assay
showed that F2r knockdown by siRNA led to decreased RhoA
activity (66% ± 8.6%; p = 0.0165) in day 4 whole EBs, further
suggesting that RhoA activity is negatively correlated with hema-
topoietic potential (data not shown). In an effort to further clarify
the role of RhoA/ROCK signaling, we used both flow cytometry
and qPCR as readouts and examined the effects of a constitu-
tively active form of RhoA, RhoA-CA (Q63L), alone and in combi-
nation with SCH79797 (Figures 3A and 3B), and further
compared the effects of Y-27632 in the presence and absence
of overexpressed F2r (Figures 3C and 3D). These data support
the idea that F2r and RhoA/ROCK work together to control
hematopoietic differentiation.
There are two sequential steps during mESC hematopoietic
differentiation: (1) the formation of flk1+ hemangioblasts,
common progenitors of endothelial and hematopoietic cells,
followed by the transition from hemangioblasts to hemogenic
endothelial cells, and (2) generation of CD41+ hematopoietic
cells via EHT (Eilken et al., 2009; Lancrin et al., 2009). To
substantiate which step the F2r-RhoA/ROCKpathway regulates,
flk1+ hemangioblasts were sorted from day 4 EBs and analyzed
by blast colony-forming cell (BL-CFC) assay (Kennedy et al.,
1997). Consistent with previous observations (Eilken et al.,
2009; Lancrin et al., 2009), sorted hemangioblasts first formed
tightly adherent hemogenic endothelial cell colonies in BL-CFC
medium, which then gradually budded off nonadherent hemato-
poietic cells (EHT). SCH79797 or Y-27632 treatment did not
affect flk1+ cell percentage in day 4 EBs (Figures S2C–S2H)
but significantly accelerated EHT 48 hr after seeding in BL-
CFC medium, destabilizing the tight junctions of hemogenic
endothelial cells (Figure 3E). These results were also confirmed
by F2r knockdown experiments (Figure 3E). To verify the causal
relationship between tight junction dissolution and EHT, we
knocked down ZO-1 using siRNA (Figure S2I) and found that
CD41+ cell percentage and the expression of hematopoietic
marker genes were significantly increased (Figures 3F and 3G)er Inc.
Figure 2. Pharmacological or Genetic Inhibition of F2r Promotes mESC Hematopoietic Differentiation
(A–C) Representative flow cytometry plots.
(D) Dose effect of SCH79797 on mESC hematopoietic differentiation.
(E) qPCR analyses of hematopoietic marker genes.
(F and G) Methylcellulose colony-forming cell assay (M3434). Ery-P colonies were scored 6 days after culture in M3434 (F). Other colonies were scored 10 days
after culture in M3434 (G). Insets show average distribution of hematopoietic colonies. cfu-G/M/GM, granulocytes/macrophages/granulocyte-macrophages;
cfu-GEMM, granulocyte/erythroid/myeloid-megakaryocytes. Pictures show representative colony morphologies.
(H) Flow cytometry analyses of F2r knockdown effects on CD41+ cells percentage.
(I) qPCR analyses of hematopoietic marker genes.
(J and K)Methylcellulose colony-forming cell assay (M3434) for two independent siRNAs. Primitive (J) and definitive (K) colonieswere cultured and scored as in (F)
and (G).
Data shown are the mean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 versus the corresponding control. See also
Figure S1.
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Figure 3. Inhibition of F2r-RhoA/ROCK Pathway Promotes EHT In Vitro
(A) Flow cytometry analyses of CD41+ cell percentage.mESCs stably expressing vector orRhoA-CAwere differentiated as EBs and treatedwith DMSOor 100 nM
SCH79797 from day 2 to day 6.
(B) qPCR analyses of hematopoietic transcription factors for day 6 whole EBs treated as in (A).
(C) Flow cytometry analyses of CD41+ cell percentage.mESCs stably expressing vector or mouse F2rwere differentiated as EBs and treatedwith DMSOor 10 mM
Y-27632 from day 2 to day 6.
(D) qPCR analyses of hematopoietic transcription factors for day 6 whole EBs treated as in (C).
(E) Confocal microscopy analyses of tight junctionmarkers in hemogenic endothelial cell colonies. Flk1+ cells were sorted from day 4 EBs and cultured in BL-CFC
medium. ZO-1, F-actin, and DAPI staining was performed 48 hr later, followed by multilayer confocal scanning and z stack processing. DIC, differential inter-
ference contrast.
(F) Effect of ZO-1 knockdown on CD41+ cell percentage.
(G) qPCR analyses of hematopoietic marker genes affected by ZO-1 knockdown in day 6 whole EBs.
Data shown are the mean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 versus the corresponding control. See also
Figure S2.
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suggesting that tight junction dissolution is a prerequisite of
EHT. Interestingly, RhoA was previously shown to negatively
regulate TGF-b induced EMT by stabilizing tight junctions
between epithelial cells (Kong et al., 2008; Ozdamar et al.,
2005). Thus, these results implicated RhoA/ROCK pathway as
a conserved negative regulator of both EMT and EHT by modu-
lating tight junctions.
F2r-RhoA/ROCK Pathway Regulates EHT In Vivo
Next, we used both pharmacological and genetic approaches
to explore the function of F2r signaling during zebrafish hemato-
poiesis. The effects of SCH79797 treatment or F2r morpholino
(F2r MO1) injection were dose dependent, and we found that
300 nM SCH79797 treatment or 4 ng F2r MO1 injection did not
significantly affect zebrafish development (data not shown).
WISH analyses showed that F2r inhibition had minimal effects
on ICM markers gata1 (Figures S3A–S3D) and scl (Figures
S3E–S3H) at 24 hpf but significantly increased the expression
of HSCmarkers cmyb and runx1 (cmyb/runx1) in the AGM region
at 36 hpf (Figure S3J, n = 62/94; Figure S3L, n = 43/59), which
was confirmed by qPCR analyses (Figures S3Q and S3R). The
vasculature was not disrupted by F2r inhibition, as evident
from Tg(flk1:EGFP) embryo imaging at 36 hpf (Figures S3M–
S3P).
Injection of another translational blocking morpholino (F2r
MO2), which binds to the 25 nucleotides upstream of ATG and
thus cannot block F2r mRNA overexpression, confirmed the
WISH results of F2r MO1 (Figure 4A; data not shown). Impor-
tantly, F2rmRNA overexpression repressed cmyb/runx1 expres-
sion and rescued the F2rMO2 effects (Figure 4B). In contrast, the
expression of myeloid marker mpx in the CHT region (Figures
S4A–S4E) and the lymphoid marker rag1 in the thymus was not
significantly changed after F2r inhibition (Figures S4F–S4J),
and we found no expansion of gata1+lmo2+ erythromyeloid
progenitors (EMPs) in the posterior blood island (PBI) at 30 hpf
(Figures S4K–S4Q, n = 5) (Bertrand et al., 2007, 2010b).
Consistent with the in vitro mESC hematopoietic differentia-
tion model, Y-27632 treatment, or injection of the dominant-
negative form of RhoA, RhoA-DN (T19N), promoted cmyb/
runx1 expression (data not shown). Moreover, epistatic analyses
showed that RhoA/ROCK pathway mediates the downstream
signaling of F2r (Figures 4C and 4D). Given that F2r-RhoA/
ROCK pathway negatively regulates transition from hemogenic
endothelial cells to hematopoietic cells in vitro, we hypothesize
that it may function similarly during HSC induction in vivo, which
also involves EHT (Bertrand et al., 2010a; Boisset et al., 2010;
Kissa and Herbomel, 2010). To test this hypothesis, we gener-
ated Tg(cmyb:EGFP; flk1:mCherry) double-transgenic zebrafish
embryos to document in vivo EHT events (Figure 4E). Consistent
with previous findings (Bertrand et al., 2010a), four-dimensional
confocal live-imaging experiments showed that HSCs emerge
from the ventral wall of dorsal aorta (DA) in an asynchronous
way: first from cmybflk1+ cells to cmyb+flk1+ cells, which then
gradually became cmyb+flk1 cells as they matured and
migrated toward the axial vein (AV). The EHT frequency was
0.21 cells per somite per hour in the DMSO-treated group
(Figures 4F–4H, n = 7; Movie S1), whereas SCH79797 (Figures
4I–4K, n = 5; Movie S1) or Y-27632 (Figures 4L–4N, n = 7; MovieDevelopmS1) treatment significantly increased this number to 0.32 and
0.37 cells per somite per hour, respectively (Figure 4X). Consis-
tently, the EHT frequency was 0.23 per somite per hour in the
control MO injection group (Figures 4O–4Q, n = 4; Movie S2),
whereas F2r MO1 (Figures 4R–4T, n = 6; Movie S2) or F2r
MO2 (Figures 4U–4W, n = 5; Movie S2) injection increased this
number to 0.35 and 0.34 cells per somite per hour, respectively
(Figure 4Y). Taken together, these data demonstrated that
F2r-RhoA/ROCK pathway negatively regulates EHT and HSC
induction in zebrafish.
DISCUSSION
F2r plays fundamental roles in coagulation, inflammation, and
carcinogenesis; however, its regulatory functions during embry-
onic development remain unclear (Coughlin, 2005). Here, using
mESCs and zebrafish as model systems, we demonstrated that
F2r signaling functions as an evolutionarily conserved pathway
regulating embryonic hematopoiesis and EHT. Interestingly, inhi-
bition of F2r signaling promotes transition from endothelial to
hematopoietic cells, whereas F2r receptor knockout leads to
vasculature damage and severe bleeding (Griffin et al., 2001).
Thus, F2r signaling seems to act as an important molecular
switch, keeping the balance between hematopoietic and
vascular development. The effect of F2r inhibition on adult
hematopoiesis in the kidney marrow was also tested, but we
were unable to detect significant changes (data not shown), sug-
gesting that F2r inhibition probably does not increase the number
of endothelial cells that are specified to HSC fate but, rather,
increases the rate of HSC induction through accelerating EHT.
Previous studies showed that endothelial-specific depletion
of G13 generated a phenotype that is nearly identical to F2r
knockout mice (Ruppel et al., 2005), suggesting that G13-
coupled mechanisms may account for the function of F2r during
early development. Consistently, our findings demonstrated that
RhoA/ROCK pathway, which is activated by G13, mediates F2r
signaling during hematopoiesis, emphasizing the importance of
F2r-G13-RhoA/ROCK axis during vertebrate embryogenesis.
The PAR family also includes PAR2, PAR3, and PAR4 (Coughlin,
2000). In contrast to F2r (PAR1), PAR2 is constitutively downre-
gulated during hematopoietic development, whereas PAR3 and
PAR4 show no significant expression changes (data not shown),
implicating that the distinctive expression pattern of F2r deter-
mines its important functions during hematopoietic develop-
ment. It is tempting to speculate that other G13-coupled GPCRs
may have similar functions in fine-tuning the developmental
processes, possibly with the same mechanisms.
EHT is a fundamental process for hematopoietic stem and
progenitor cell induction. Likewise, EMT also plays pivotal roles
during different stages of gastrulation (Thiery et al., 2009), and
ectopic induction of EMT in mammary epithelial cells generates
mammary stem cell-like cells (Mani et al., 2008). In this study, we
provided evidence that RhoA/ROCK pathway, a known regulator
of EMT, also modulates EHT, linking the two different cell transi-
tions with a conserved mechanism. Up until now, the only re-
ported EHT regulator is Runx1, which is a key transcription factor
responsible for initiation of EHT but is dispensable thereafter
(Chen et al., 2009). Our findings highlight the notion that EHT is
also tightly regulated by environmental factors. Given thatental Cell 22, 1092–1100, May 15, 2012 ª2012 Elsevier Inc. 1097
Figure 4. Inhibition of F2r-RhoA/ROCK Pathway Promotes EHT and HSC Induction In Vivo
(A) WISH analyses of cmyb/runx1 expression at 36 hpf. A total of 4 ng Ctrl MO or F2r MO2 was injected at one-cell stage. The AGM regions were shown with the
anterior to the left.
(B) Quantification of cmyb/runx1-positive HSCs per AGM. A total of 4 ng F2rMOor 400 pg F2rmRNAwas injected alone or in combination at one-cell stage.WISH
analyses were performed at 36 hpf, followed by quantification (nR 5).
(C and D) Epistasis analyses of F2r-RhoA/ROCK pathway in zebrafish. Embryos injected with 20 pg humanRhoAWT orRhoA-CA (Q63L)mRNA, and treated with
DMSO or 100 nM SCH79797 from 12 to 36 hpf (C). Embryos injected with 400 pg control or zebrafish F2rmRNA, and treated with DMSO or 10 mMY-27632 from
12 to 36 hpf (D). Riboprobes to cmyb and runx1 were stained simultaneously at 36 hpf, followed by WISH quantification (nR 5).
(E) Global view of the imaging position in Tg(cmyb:EGFP; flk1:mCherry) double-transgenic zebrafish. The square indicates the live-imaging position.
(F–W) Time-lapse confocal microscopy analyses of in vivo EHT. Representative pictures were captured from Movie S1 after DMSO (F–H), 300 nM SCH79797
(I–K), or 10 mM Y-27632 treatments (L–N) starting at 12 hpf, and from Movie S2 after 4 ng Ctrl MO (O–Q), 4 ng F2r MO1 (R–T), or 4 ng F2r MO2 (U–W) injections.
Multilayer confocal scanning was performed from 32 to 48 hpf, followed by z stack processing. DA, dorsal aorta; AV, axial vein. Arrowheads indicate cells that are
undergoing EHT. Note that dorsal neurons are nonspecifically labeled in these embryos, whereas the cmyb+ cells under the AV were hematopoietic precursors.
(X and Y) Statistical analyses of EHT frequency.
Data shown are the mean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 versus the corresponding control. See also Figures
S3 and S4 and Movies S1 and S2.
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(Etienne-Manneville and Hall, 2002), it is very likely that modula-
tion of other upstream receptors may also affect EHT. Impor-
tantly, recent studies showed that Oct4 is sufficient to transform
skin fibroblasts into hematopoietic cells, although at a relatively
low efficiency (Szabo et al., 2010). Inhibition of F2r-RhoA/ROCK
pathway appears to be an effective strategy to promote induc-
tion of hematopoietic stem and progenitor cells, enabling the1098 Developmental Cell 22, 1092–1100, May 15, 2012 ª2012 Elsevipotential treatment of hematopoietic diseases, such as Fanconi
anemia or leukemia.EXPERIMENTAL PROCEDURES
Microarray Data Analyses
All statistical computations were performed by R (http://www.r-project.org),
and in-house scripts are available upon request. Raw microarray data seter Inc.
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accession numbers GSE2972 and GSE3749 (Edgar et al., 2002). Standard
Affymetrix quality assessment procedures were performed with BioConductor
packages simpleaffy (Wilson and Miller, 2005) and AffyPLM (Bolstad et al.,
2003). Expression values among arrays were further normalized and estimated
using the RMA algorithm (Irizarry et al., 2003). To identify differentially ex-
pressed genes (DEGs) during the differentiating process, a moderated linear
model was employed with time point 0 hr as the ‘‘baseline’’ (Smyth, 2004).
Raw p values derived from empirical Bayes testing were further corrected by
the BH95 procedure for multiple hypothesis testing (Benjamini and Hochberg,
1995). Only genes with corrected p values less than 0.05 and fold changes
larger than 1.5 were identified as DEGs. The putative mouse GPCR list was
retrieved from GPCRDB (Horn et al., 1998), and the diverged sequence
identities were mapped to NCBI RefSeq identities by sequence comparison
using NCBI BLAST. Differentially expressed GPCRs were further identified
by intersecting with the aforementioned DEG list.
Hematopoietic Differentiation of mESCs
All mESC culture and hematopoietic differentiation procedures followed
standard protocol (McKinney-Freeman et al., 2008). Briefly, undifferentiated
mESCs were cultured in DMEM, and changed to IMDM 2 days before hema-
topoietic differentiation. To form hematopoietic EBs, mESCs were dissociated
into single cells using trypsin, diluted at 100 mESCs/15 ml differentiation
medium (200 mg/ml holo-transferrin, 4.5 mM monothioglycerol, 15% differen-
tiation serum, 50 mg/ml ascorbic acid in IMDM), and cultured in an inverted
manner. EBs were pooled into 35 mm Petri dish at day 2, and cultured with
rotation for another 4 days. Fresh differentiation medium was changed every
2 days. Stable mESC lines were constructed by lentivirus transfection and
flow cytometry sorting based on GFP expression. Methylcellulose-based
colony-forming cell assay was performed according to the manufacturer’s
instructions (M3434; STEMCELL Technologies). BL-CFC assay was per-
formed as previously described (Kennedy et al., 1997).
Real-Time qPCR
Total RNAs were extracted from whole EBs or 20 embryos using TRIzol
reagent (Sigma-Aldrich). RNA was reverse transcribed using random hexam-
ers and M-MLV Reverse Transcriptase (Promega). A 23 PCR Mix (Tiangen)
and Eva Green (Biotium) were used for the real-time qPCR analysis, with an
MX3000P Stratagene PCR machine. The relative expression values were
normalized against the internal control gapdh. Primer sequences are listed in
Supplemental Experimental Procedures.
Flow Cytometry
Cells were resuspended in PBS containing 1% (wt/vol) BSA (Sigma-Aldrich).
For surface staining of CD41 and flk1, cells were incubated on ice for 30 min
with fluorochrome-conjugated antibodies at 1:50 dilution ratio. Stained cells
were washed twice and analyzed with FACSAria (BD Biosciences). Results
were processed using FlowJo software.
Zebrafish Maintenance and Embryo Production
Zebrafish maintenance, breeding, and staging were performed as described
previously (Kimmel et al., 1995).
Morpholinos and siRNAs
Morpholino antisense oligonucleotides (MOs) were obtained from Gene Tools.
siRNAs were designed and synthesized by GenePharma. The sequence infor-
mation for MO and siRNA is listed in Supplemental Experimental Procedures.
In Vitro RNA Synthesis and WISH
Antisense riboprobes were synthesized using the DIG RNA Labeling kit
(Roche) according to the manufacturer’s instructions. mRNAs were synthe-
sized using mMessage mMachine kit (Ambion). WISH was performed as
previously described (Kissa et al., 2008).
Fluorescence Microscopy
Leica SP5 inverted confocal microscope (Leica) was used for all confocal
experiments. Four-dimensional time-lapse imaging was performed as previ-
ously described with modifications (Bertrand et al., 2010a). z stacks wereDevelopmtaken every 10 min from 32 to 48 hpf. Movies were created after processing
with LAS AF software (Leica). Tg(flk1:EGFP) images were acquired by
Olympus SZX16 system.
Statistical Analysis
Quantitative data were expressed as mean ± SEM of at least three indepen-
dent experiments. Statistical significance was determined by two-tailed
Student’s t test, or by one-way analysis of variance (ANOVA) followed by
LSD post hoc test for multiple comparisons. A p value less than 0.05 was
considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, two movies, and Supple-
mental Experimental Procedures and can be found with this article online at
doi:10.1016/j.devcel.2012.01.025.
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